Anti-tumor necrosis factor-induced lupus in patients with inflammatory bowel disease: a hospital-based cohort study from Korea

BACKGROUND: Anti-tumor necrosis factor (TNF) agents are increasingly used for rheumatic diseases and inflammatory bowel disease (IBD), but are associated with the development of anti-TNF-induced lupus (ATIL). Nonetheless, few ATIL studies on non-Caucasian IBD patients exist. Here, we investigated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Su Jin, Ahn, Soo Min, Oh, Ji Seon, Hong, Seokchan, Lee, Chang-Keun, Yoo, Bin, Ye, Byong Duk, Yang, Suk-Kyun, Park, Sang Hyoung, Kim, Yong-Gil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940731/
https://www.ncbi.nlm.nih.gov/pubmed/33747126
http://dx.doi.org/10.1177/1756284821997794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940731/
https://www.ncbi.nlm.nih.gov/pubmed/33747126
http://dx.doi.org/10.1177/1756284821997794

Ejemplares similares